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itotic cell rounding is the process of cell shape
change in which a ﬂat interphase cell becomes
spherical at the onset of mitosis. Rearrangement
of the actin cytoskeleton, de-adhesion, and an increase in
cortical rigidity accompany mitotic cell rounding. The
molecular mechanisms that contribute to this process have
not been deﬁned. We show that RhoA is required for cortical
retraction but not de-adhesion during mitotic cell rounding.
The mitotic increase in cortical rigidity also requires RhoA,
suggesting that increases in cortical rigidity and cortical
retraction are linked processes. Rho-kinase is also required
M
 
for mitotic cortical retraction and rigidity, indicating that
the effects of RhoA on cell rounding are mediated through
this effector. Consistent with a role for RhoA during mi-
totic entry, RhoA activity is elevated in rounded, preana-
phase mitotic cells. The activity of the RhoA inhibitor
p190RhoGAP is decreased due to its serine/threonine
phosphorylation at this time. Cumulatively, these results
suggest that the mitotic increase in RhoA activity leads to
rearrangements of the cortical actin cytoskeleton that promote
cortical rigidity, resulting in mitotic cell rounding.
 
Introduction
 
Mitotic cell rounding is the process in which a flat interphase
cell changes shape to become more spherical in mitosis. This
process occurs concurrent with nuclear envelope breakdown
at the onset of mitosis and is completed before anaphase,
when cells often elongate to a more oval shape before under-
going cytokinesis (for review see Glotzer, 2001). Mitotic cell
rounding is likely important for chromosome segregation
and the positioning of the cytokinetic furrow. Although it
has been described for several types of cultured mammalian
cells (Harris, 1973; Sanger et al., 1984; Cramer and Mitchison,
1997), a mechanism for mitotic cell rounding has not been
well defined. Interestingly, it has been shown for several
species that eggs become “more round” in mitosis. The mitotic
surface contraction waves of 
 
Xenopus laevis
 
 eggs cause them
to become taller and more spherical (Hara et al., 1980).
Cortical rigidity measured with a suction pipet, and resistance
to external pressure, increases as sea urchin eggs enter mito-
sis (Mitchison and Swann, 1955; Yoneda and Dan, 1972).
Matzke et al. (2001) used atomic force microscopy to show
that mammalian tissue culture cells (Ptk2) are more rigid in
metaphase of mitosis than in interphase.
Mitotic cell rounding is accompanied by changes in the
actin cytoskeleton. In interphase of many types of cultured
cells, actin is predominantly organized into stress fibers that
span the cytoplasm. Upon entry into mitosis, stress fibers
disassemble and actin localizes primarily to the increasingly
round cortex. Cramer and Mitchison (1997) showed that
filamentous actin (F-actin) is required for coordinated re-
traction of the cell margin at the onset of mitosis, demon-
strating that the actin cytoskeleton plays an active role in
mitotic cell rounding. The enrichment of F-actin in the
spherical cortex in mitosis could be favored by the cross-
linking of actin filaments into a meshwork. Several actin-
binding proteins can support such cross-linking, including
filamin, spectrin, and 
 
 
 
-actinin. Evidence that actin cross-
linking promotes a rounded morphology comes from Cortese
et al. (1989). The inclusion of filamin in actin-containing
vesicles caused the vesicles to become smooth and spherical
upon actin polymerization, whereas an irregular, angular
morphology occurred in the absence of filamin (Cortese et
al., 1989). Adhesions to the substrate are also altered in
mitosis but remain connected to the cell via retraction fibers,
which are exposed as the cell rounds. Structural and signaling
proteins resident to focal adhesions become diffusely local-
ized within the cytoplasm (Sanger et al., 1987; Hock et al.,
1989; Yamakita et al., 1999). Plating cells on flexible sub-
strates revealed that intracellular tension transmitted to the
substrate through focal adhesions decreases during entry
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into mitosis (Burton and Taylor, 1997). Here, we will refer
to this disassembly of focal adhesions as de-adhesion.
The Rho family of small GTPases regulates actin organi-
zation and therefore cell shape (Van Aelst and D’Souza-
Schorey, 1997; Hall, 1998). One of the best-characterized
members of this family is RhoA. Many RhoA effectors lead
to remodeling of the actin cytoskeleton. The RhoA effector
Rho-kinase stimulates the myosin II regulatory light chain
Figure 1. RhoA is required for cortical retraction but not de-adhesion during mitotic cell rounding. HeLa cells growing on glass coverslips 
were treated with recombinant GST–C3 toxin or GST alone (0.28  g per 24-well plate well) by introduction with LipofectAmine reagent for 
90 min. Cells were fixed and stained for F-actin, paxillin, and DNA. Cells in metaphase of mitosis were identified as having a metaphase plate 
of aligned chromosomes. For metaphase cells, diameter, perimeter, and area were measured by drawing on the phase image (C, D, Q, and 
R). The diameter measurement reported is the cell diameter (black line) bisecting and perpendicular to the diameter that passes through the 
metaphase plate (gray line). GST-treated metaphase cells are well rounded, whereas GST–C3-treated metaphase cells are not completely rounded 
(compare C with D). Bar, 15  m. (S) Quantitation of measurements of mitotic cells. Measurements are averages and standard deviations from 
one of three equivalent experiments. n   21 for each experiment. *, significant difference from GST (P   0.0005).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
RhoA and mitotic cell rounding |
 
 Maddox and Burridge 257
 
(MLC)* directly by phosphorylation and indirectly by inhi-
bition of myosin phosphatase (Amano et al., 1996; Kimura
et al., 1996). Another RhoA effector, citron kinase, also acti-
vates MLC by phosphorylation (Matsumura et al., 2001).
Activation of MLC leads to actomyosin contractility, bun-
dling, and cross-linking of actin filaments, and thus the for-
mation and maintenance of actin stress fibers (Chrza-
nowska-Wodnicka and Burridge, 1996). The RhoA effector
mDia, which promotes actin filament bundling, also con-
tributes to proper stress fiber formation (Watanabe et al.,
1997, 1999). Additionally, RhoA activity regulates the actin
cytoskeleton by affecting actin filament assembly dynamics.
RhoA, via Rho-kinase, stimulates LIM-kinase (LIMK),
which down-regulates the actin-severing protein cofilin by
phosphorylation (Maekawa et al., 1999; Sumi et al., 1999).
Inhibition of RhoA by treatment with C3 toxin causes disso-
lution of stress fibers and cell rounding in interphase cells
(Paterson et al., 1990; Wiegers et al., 1991). The latter is
thought to occur because inhibition of RhoA results in de-
creased focal adhesions and substrate adhesions in general.
When RhoA is inhibited with C3 in mitotic cells, the actomyo-
sin cytokinetic furrow is blocked (Kishi et al., 1993). Likewise,
Y-27632, a specific inhibitor of Rho-kinase, causes dissolution
of stress fibers and retraction of the cell margin (Uehata et al.,
1997), and blocks MLC phosphorylation and furrow ingression
during cytokinesis (Kosako et al., 2000). Interestingly, in earlier
stages of mitosis, C3 treatment resulted in the spreading of the
treated prophase cell as it was pulled by neighboring cells in a
confluent monolayer of epithelial cells (O’Connell et al., 1999).
The authors suggest that RhoA regulates the “mechanical integ-
rity and strength of the cortex” (O’Connell et al., 1999). We
hypothesized that RhoA mediates mitotic reorganization of the
actin cytoskeleton, and that this rearrangement promotes corti-
cal rigidity in mitosis and mitotic cell rounding.
Here we examine the role of RhoA in mitotic cell round-
ing. We show that RhoA is required for cortical retraction,
but not de-adhesion during rounding. RhoA is also required
for increases in cortical rigidity as cells enter mitosis, suggest-
ing that cortical retraction and increased cortical rigidity are
linked processes. Consistent with a role during this cell cycle
transition, RhoA activity is elevated in preanaphase mitotic
cells compared with interphase cells. The negative regulator
of RhoA, p190RhoGAP, is less active at metaphase than in
interphase and this down-regulation may play a role in mi-
totic stimulation of RhoA.
 
Results
 
RhoA is required for cortical retraction but not 
de-adhesion during mitotic cell rounding
 
Mitotic cell rounding is comprised of at least two indepen-
dent processes: de-adhesion and cortical retraction. De-
adhesion is the dissolution of stress fibers and focal adhesions
and the dispersal of the component proteins. This has been
described for several stress fiber and focal adhesion proteins
(Sanger et al., 1987; Hock et al., 1989; Sanger et al., 1989).
During cortical retraction, the cell cortex changes from well
spread and flattened to spherical and refractile by phase con-
trast imaging. To examine whether RhoA has a role in either
of these processes, we treated HeLa cells with a GST fusion
with C3 toxin (C3), an inhibitor of RhoA. This treatment
significantly reduces RhoA-GTP levels but does not inhibit
the related GTPase Rac1 (unpublished data). To test for a
role in de-adhesion, we first stained control and C3-treated
cells with an antibody to paxillin, a component of focal ad-
hesions, and with phalloidin to follow changes in the actin
cytoskeleton. To ensure that cells were at or near the end-
point of mitotic rounding, only cells with a metaphase plate
of condensed, aligned chromosomes were imaged (Fig. 1, O
and P). We found that in C3-treated cells and GST-treated
control cells, paxillin is diffusely localized in mitotic cells
(Fig. 1, compare I with K and J with L). Also, actin stress fi-
bers are absent in mitotic C3-treated cells, as in control cells
(Fig. 1, compare E with G and F with H). This suggests that
RhoA activity is not required for de-adhesion.
The phase contrast and phalloidin staining images of mi-
totic cells treated with C3 show that cortical retraction fails
Figure 2. Rho-kinase is required for cortical retraction during 
mitotic cell rounding. HeLa cells were treated with Y-27632 or 
vehicle alone (Control) in growth medium for 1 h. Cells were fixed 
and stained for F-actin and DNA. Phase contrast and fluorescence 
images are shown. Bar, 15  m. (G) Cortical retraction was quantified 
as for Fig. 1. Measurements are averages and standard deviations 
from one of three equivalent experiments. n   30 for each experiment. 
*, significant difference from Control (P   0.0005).
 
*Abbreviations used in this paper: GAP, GTPase activating protein;
GEF, guanine nucleotide exchange factor; LIMK, LIM-kinase; MLC,
myosin II regulatory light chain; PP1, protein phosphatase 1.T
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to result in a spheroid cell shape in these RhoA-inhibited
cells (Fig. 1, C, D, G, and H). Rather, mitotic C3-treated
cells have undergone a similar degree of cortical retraction as
interphase C3-treated cells (Fig. 1, B and D). To quantify
the involvement of RhoA in cortical retraction, we com-
pared the area, perimeter, and diameter of cells treated with
C3 to that of control GST-treated cells (Fig. 1, Q and R; see
legend for more measurement details). We found that by all
three criteria, cortical retraction was significantly inhibited
in C3-treated cells compared with cells treated with GST
alone (Fig. 1 S; Diameter: GST, 26.6 
 
 
 
 6.3 
 
 
 
m; GST–C3,
33.6 
 
 
 
 7.5 
 
 
 
m; Perimeter: GST, 86.1 
 
 
 
 17.9 
 
 
 
m; GST–
C3, 148.0 
 
 
 
 47.7 
 
 
 
m; Area: GST, 435.4 
 
 
 
 162.7 
 
 
 
m
 
2
 
;
GST–C3, 744.4 
 
 
 
 241.8 
 
 
 
m
 
2
 
). This was also seen with
CHO and A431 cells (unpublished data). In contrast to the
decreased rounding seen with mitotic cells treated with C3,
interphase cells treated with C3 were more rounded and re-
fractile than GST-treated cells and had decreased actin stress
fibers and focal adhesions, as has been observed previously
(Paterson et al., 1990; Wiegers et al., 1991; Fig. 1, A, B, E,
F, I, and J). Phalloidin staining of F-actin also showed that
C3-treated mitotic cells lack the circular band of F-actin
seen in GST-treated rounded mitotic cells (Fig. 1, G and
H). From these results, we conclude that RhoA is required
for cortical retraction, but not de-adhesion, during mitotic
cell rounding, and that the requirement for RhoA in cortical
retraction may involve RhoA-regulated actin reorganization.
 
Inhibition of Rho-kinase also results in defects in 
cortical retraction during mitotic cell rounding
 
Rho-kinase is a RhoA effector that plays an important role
in transducing signals from RhoA to the actin cytoskeleton
(Leung et al., 1995; Ishizaki et al., 1996; Kimura et al.,
1996). Therefore, we investigated whether Rho-kinase is
also required for cortical retraction during mitotic cell
rounding. HeLa cells were treated with the Rho-kinase in-
hibitor Y-27632, and cells in metaphase of mitosis were as-
sessed for degree of rounding by measuring diameter, perim-
eter, and area. As was the case for the C3-treated cells, by all
three criteria, cortical retraction was significantly inhibited
Figure 3. RhoA is required for rigidity of rounded mitotic cells. (A) Phase images of HeLa cells and the microneedle show the needle in 
contact with the cell before application of pressure (0) and after needle movement of various distances (shown in microns across the top). The 
location of the needle shaft after movement of 125  m and release from the cell by lifting is shown in the last frame of each panel. A cell 
treated with GST (top panel) is not deformed by pressure exerted by the needle. A cell treated with GST–C3 (bottom panel) is deformed by 
pressure more than the GST-treated cell; the needle tip moves further when a given amount of pressure is applied to the GST–C3 cell than 
when it is applied to the GST-treated cell. Bar, 125  m. (B) Cell rigidity is plotted as force versus distance of deformation (see Materials and 
methods). Data points are averages and standard deviations (GST, black diamonds; GST–C3, gray squares). Linear regressions are plotted; 
slopes correspond to cell rigidity. *, significant difference from GST treatment (P   0.0005). n   25 for each treatment. The values for Y-27632 
treatment are included in the text.T
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in Y-27632–treated cells compared with controls (Fig. 2 G;
Diameter: Control, 17.0 
 
 
 
 2.2 
 
 
 
m; Y-27632, 19.9 
 
 
 
 3.2
 
 
 
m; Perimeter: Control, 53.7 
 
 
 
 6.8 
 
 
 
m; Y-27632, 61.9 
 
 
 
10.6 
 
 
 
m; Area: Control, 206.6 
 
 
 
 42.2 
 
 
 
m
 
2
 
; Y-27632,
254.8 
 
 
 
 60.7 
 
 
 
m
 
2
 
). Phalloidin staining of F-actin reveals
that the intense circular band on actin in control mitotic
cells is absent in Y-27632–treated cells (Fig. 2, C and D).
These results show that Rho-kinase is likely a key effector
that mediates the RhoA dependency of cortical retraction
during mitotic cell rounding.
 
RhoA and Rho-kinase are required for cortical rigidity 
in rounded preanaphase mitotic cells
 
In addition to cell rounding, entry into mitosis is also accom-
panied by an increase in cell rigidity (Mitchison and Swann,
1955; Yoneda and Dan, 1972; Matzke et al., 2001). Because
it seemed likely that the same reorganization of the cortical
cytoskeleton is required for cortical retraction during cell
rounding and mitotic cortical rigidity, we hypothesized that
RhoA is required for both processes. To determine whether
RhoA is required for cells to become more rigid as they enter
mitosis, we treated cells with C3, as for Fig. 1, and tested the
rigidity of preanaphase mitotic cells (identified as having a
metaphase plate of chromosomes by phase contrast imaging).
To do this, a micromanipulation needle was brought into
contact with the subject cell, and controlled increments of
pressure were exerted on the cell by moving the needle shaft
set distances. Images of the location of the needle tip and cell
were captured and used to quantify the cells’ resistance to
pressure. Control mitotic cells resist pressure; they are not de-
formed by the needle (Fig. 3 A, top). Under the same
amounts of pressure, a C3-treated mitotic cell is deformed
visibly by the needle (Fig. 3 A, bottom). Cell rigidity is signif-
icantly decreased by the C3 treatment (Fig. 3 B; GST:
 
 
 
0.119, GST–C3: 
 
 
 
0.210; see Materials and methods for
quantitation details). Mitotic cells treated with Y-27632 to
inhibit Rho-kinase are significantly less rigid than control
cells (Control: 
 
 
 
0.237 
 
 
 
 0.098; Y-27632: 
 
 
 
0.425 
 
 
 
 0.14*;
an asterisk indicates a significant difference from control;
P 
 
 
 
 0.0005.) From these results, we conclude that RhoA and
Figure 4. RhoA activity is elevated in mitosis. (A) RhoA activity was measured in lysates from control interphase adherent HeLa cells (Con), 
cells that had been rounded with trypsin (Tryp), or mitotic cells harvested by the knock-off method from untreated asynchronous cultures 
(Mit). RhoA immunoblots show RhoA protein levels in pull-downs (Active RhoA) and lysates (Total RhoA). *, significant difference from control 
(for all panels) (P   0.05). Bars represent SEM. All data shown are representative of at least five replicate experiments. (B) HeLa cells were 
treated with nocodazole for 30 min (30’NZ) or overnight. For overnight treatment, rounded mitotic cells were harvested by knock-off (NZMit), 
with the remaining adherent cells in interphase (ON-NZ). (C) HeLa cells were treated with taxol for 30 min (30’TX) or overnight. Rounded 
mitotic cells (TXMit) that had accumulated during the overnight treatment were harvested by knock-off. Remaining interphase cells comprised 
the overnight interphase (ON-TX) sample. (D) HeLa cells were synchronized in G1 by a single thymidine block followed by a brief nocodazole 
block and then a washout to allow progression through mitosis and into G1 of interphase. Cells were synchronized in S phase with a double 
thymidine block, and in G2 with a double thymidine block followed by a 5-h washout. Rounded mitotic cells were harvested from cultures 
that were treated with taxol for 4 h after washout from a single thymidine block. (E) Staining of HeLa cell nuclei with Hoechst shows normal 
morphology with all treatments. (E, a) Untreated interphase cell, (b) untreated mitotic cell, (c–f) treated with 10 nM taxol, (c) 30’ treatment 
(interphase cell), (d) overnight treatment (interphase cell), (e) overnight treatment (mitotic cell), (f) overnight treatment (cells harvested as rounded 
mitotic cells and fixed 7 h after washout, now interphase). Note that taxol does not cause the nuclear condensation characteristic of apoptosis 
at the concentration and time course used. Bar, 15  m.T
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Rho-kinase are required for both cortical retraction and in-
creases in cortical rigidity as cells enter mitosis, and that these
processes are likely linked.
 
RhoA activity is higher in preanaphase mitotic cells 
than in interphase cells
 
The fact that RhoA is required for both cortical retraction
and increases in cortical rigidity as cells enter mitosis sug-
gests that RhoA activity increases during this cell cycle tran-
sition. To test this, we compared the activity of RhoA in
spread interphase cells with that in rounded mitotic cells.
Rounded mitotic HeLa cells were harvested from untreated
asynchronous cultures by mechanical disruption. The adher-
ent cells remaining after this “knock-off” procedure were in
interphase and comprised the control sample (Fig. 4 E, a
and b). To determine the degree of RhoA activation in each
condition, we isolated active, GTP-bound RhoA from cell
lysates using an affinity matrix consisting of the RhoA-bind-
ing domain of the RhoA effector Rhotekin fused to GST
and immobilized on sepharose beads (Ren et al., 1999). Ac-
tive RhoA associated with the beads, and total RhoA in ly-
sates was detected by immunoblotting. We found that,
whereas the total level of RhoA did not change, there was
significantly more active RhoA in lysates from mitotic cells
than in lysates prepared from interphase controls (Fig. 4 A).
The amount of active RhoA was also elevated in trypsin-
rounded interphase cells, as has been seen (Ren et al., 1999).
The mitotic population harvested from untreated cultures
contained cells at all stages of mitosis. It has been shown that
RhoA activity increases during, and is required for, cytokinesis
(O’Connell et al., 1999; Kimura et al., 2000). Therefore, it was
important to separate preanaphase cells (at the endpoint of cell
rounding) from post-anaphase cells (preparing for or perform-
ing cytokinesis). A common technique for accumulating cells
in mitosis is to use microtubule-disrupting drugs, which pre-
vent normal spindle assembly and progression from metaphase
into anaphase. However, it has been shown that microtubule-
depolymerizing drugs cause increases in RhoA-GTP activity
(Ren et al., 1999; Fig. 4 B). Therefore, we used taxol treatment
to accumulate mitotic cells. Taxol is a microtubule-stabilizing
agent that also causes cells to accumulate in mitosis at pre-
anaphase but does not stimulate RhoA activity (Ren et al.,
1999; Fig. 4 C). Significantly, cells arrested in preanaphase mi-
tosis with taxol had high RhoA activity (Fig. 4 C). This result
was also seen with REF2A rat embryo fibroblasts (unpublished
data). The cells remaining in interphase after longer taxol treat-
ments accumulated intracellular taxol and did not have ele-
vated RhoA activity (Jordan et al., 1993; Fig. 4 C). Therefore,
we conclude that taxol treatment alone does not affect RhoA
activity, and that RhoA activity is elevated in mitosis before
anaphase and cytokinesis.
Hoechst staining of DNA shows that cells treated with
this low level of taxol (10 nM) were not undergoing apopto-
sis (Fig. 4 E, c–f). Interphase cells treated with taxol for
8–12 h have normal nuclear morphology (Fig. 4 E, d). Mi-
totic taxol-treated cells had condensed chromatin before
taxol washout (Fig. 4 E, e). At 7 h after taxol washout, nuclei
have interphase morphology but are lobulated (Fig. 4 E, f).
This may be due to the abnormal mitoses (multipolar spin-
dles) that occur in taxol-treated cells (Brown et al., 1985).
We next examined whether RhoA activity is elevated at
any other stage of the cell cycle besides the elevation that oc-
curs during mitosis. We assayed RhoA activity in HeLa cells
synchronized in G1, S phase, and G2 and compared RhoA
activity at these times with that in mitosis and in asynchro-
nous cells. There is no significant difference in RhoA activity
among the various cell cycle phases other than in mitosis
(Fig. 4 D). From these results, we conclude that RhoA activ-
ity increases as cells enter mitosis. Combined with our previ-
ous data, these results further suggest that increased RhoA
activity leads to increased cortical rigidity and cortical retrac-
tion, which cause cell rounding at the onset of mitosis.
 
p190RhoGAP activity is lower in mitosis 
than in interphase
 
Rho proteins are regulated by two major families of proteins:
guanine nucleotide exchange factors (GEFs), which activate
Rho proteins by loading them with GTP, and GTPase acti-
vating proteins (GAPs), which inactivate Rho proteins by
promoting their intrinsic GTP hydrolysis activity (for review
see Bishop and Hall, 2000). Also, guanine nucleotide disas-
sociation inhibitors interact with and inhibit Rho GTPases
(Bishop and Hall, 2000). The mitotic increase in RhoA ac-
tivity is most likely due either to the activation of a GEF or
the inactivation of a GAP (Vincent and Settleman, 1999).
The recent observation that the decrease in RhoA activity
Figure 5. p190RhoGAP is tyrosine dephosphorylated, serine/
threonine phosphorylated, and decreased in activity in mitosis. 
(A) p190RhoGAP was immunoprecipitated from HeLa cells and 
probed, stripped, and reprobed for p190RhoGAP, phosphotyrosine, 
and coassociation with p120RasGAP. Note the decrease in phos-
photyrosine and p120RasGAP associated with mitotic p190RhoGAP, 
and the electrophoretic mobility shift in mitosis. (B) p190RhoGAP 
was immunoprecipitated from interphase and mitotic HeLa cells, 
and immunoprecipitates were washed into PP1 reaction buffer and 
divided into four equal samples. One sample was not treated ( ); 
the remaining three each received 1 U PP1 phosphatase. The serine/
threonine phosphatase inhibitor okadaic acid (PP1   O) and the 
tyrosine phosphatase inhibitor vanadate (PP1   V) were added to 
one sample each before PP1 was added. Note that the retarded 
electrophoretic mobility of mitotic p190RhoGAP is restored to the 
interphase mobility by PP1 treatment. (C) p190RhoGAP activity is 
lower in mitosis than in interphase as assayed for RhoA GAP activity. 
PP1 phosphatase treatment increases the activity of mitotic 
p190RhoGAP. Graphed are means from six experiments. Bars 
represent the SEM. *, significant difference from Interphase ( ); 
**, significant difference from Mitosis ( ) (P   0.05).T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
RhoA and mitotic cell rounding |
 
 Maddox and Burridge 261
 
after integrin engagement is mediated by p190RhoGAP
(Arthur et al., 2000) led us to investigate whether this nega-
tive regulatory protein was also responsible for changes in
RhoA activity in mitosis, another incidence of adhesion dy-
namics.
Tyrosine phosphorylation of p190RhoGAP has been
correlated with its activity (Fincham et al., 1999; Arthur
et al., 2000; Dumenil et al., 2000). Immunoprecipitated
p190RhoGAP bears less tyrosine phosphorylation in mitosis
than in interphase (Fig. 5 A). Also, decreased p120RasGAP
is present in p190RhoGAP immunoprecipitates in mitosis
(Fig. 5 A). These findings suggest that mitotic p190Rho-
GAP has decreased activity (Trouliaris et al., 1995). Careful
inspection of immunoprecipitated p190RhoGAP revealed
that it migrates more slowly and as a more diffuse band in
mitosis (Fig. 5, A and B). Changes in gel migration often
reflect altered levels of serine/threonine phosphorylation.
Therefore, immunoprecipitates were treated with protein
phosphatase 1 (PP1). This treatment restored the mobility
 
of mitotic p190RhoGAP to that of p190RhoGAP from in-
terphase cells (Fig. 5 B). These results suggest that in mito-
sis, p190RhoGAP has decreased phosphotyrosine, decreased
association with p120RasGAP, and an altered electro-
phoretic mobility due to increased phosphoserine or phos-
phothreonine.
Because the activation state of p190RhoGAP that is tyro-
sine dephosphorylated and serine/threonine phosphorylated
has not been characterized, it was necessary to directly mea-
sure the GAP activity of p190RhoGAP isolated from mitotic
cells. For these experiments, recombinant RhoA loaded with
[
 
 
 
-
 
32
 
P]GTP was incubated with immunoprecipitated p190Rho-
GAP. Mitotic p190RhoGAP was found to be less active
than p190RhoGAP isolated from interphase cells (Fig. 5 C).
When mitotic p190RhoGAP was incubated with PP1 phos-
phatase, its RhoA GAP activity was increased over that of
untreated mitotic p190RhoGAP, and to the activity level
of interphase p190RhoGAP (Fig. 5 C). These data demon-
strate that mitotic phosphorylation of p190RhoGAP is re-
quired for the down-regulation of p190RhoGAP that occurs
in mitosis. In addition, the mitotic decrease in phosphoty-
rosine and association with p120RasGAP and the phos-
phoserine/threonine-mediated alteration in electrophoretic
mobility of p190RhoGAP correlate with decreased GAP ac-
tivity of p190RhoGAP.
The results presented above suggest that mitotic down-
regulation of p190RhoGAP plays a role in RhoA-dependent
mitotic cell rounding. To test whether this is true, we at-
tempted to override mitotic down-regulation of p190Rho-
GAP. GFP-tagged wild-type p190RhoGAP was transiently
overexpressed in HeLa cells and mitotic cell rounding
was measured using images of cells in metaphase of mitosis.
Imaging demonstrated that cells expressing GFP–p190Rho-
GAP undergo comparable mitotic cell rounding to nonex-
pressors (Fig. 6 A). Quantitation also revealed that the level
of expression of p190RhoGAP was not predictive of cell size
at the endpoint of mitotic cell rounding (Fig. 6 B). There-
Figure 6. Transient overexpression of GFP–p190RhoGAP does 
not block mitotic cell rounding. At 24 h after transfection, HeLa 
cells were fixed, stained, imaged, and measured as for Figs. 1 and 2. 
Also measured was the total GFP fluorescence within a circular 
region of fixed size, which comprised much of the cytoplasm. (A) A 
metaphase cell expressing GFP–p190RhoGAP has undergone 
mitotic cell rounding to a similar extent as a neighboring cell 
expressing little or no GFP–p190RhoGAP. (B) The extent of mitotic 
cell rounding, measured as cell diameter, perimeter, and area, was 
plotted against the intensity of the cytoplasmic GFP signal. GFP fluo-
rescence is not predictive of the three cell rounding measurements. 
Figure 7. RhoA and Rho-kinase are required for actin reorganization, 
cortical rigidity, and cortical retraction during mitotic cell rounding. 
Black arrows denote direct or indirect stimulation as shown here or 
in the literature. Gray arrows represent possible causal relationships. 
Black lines followed by bars denote inhibition.T
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fore, using this method, we were unable to show that mitotic
down-regulation of p190RhoGAP contributes to mitotic
cell rounding.
 
Discussion
 
RhoA and Rho-kinase are required for cortical 
retraction and rigidity in mitotic cell rounding
 
In this paper, we show that RhoA is required for cortical re-
traction and rigidity as cells enter mitosis (results summarized
in Fig. 7). The idea that RhoA regulates cortical rigidity is
supported by several published observations. Treatment of
interphase cells with C3 toxin causes a collapse of the spread
morphology and the exposure of thin retraction fibers that
branch and bleb (Rubin et al., 1988; Chardin et al., 1989).
Our observation that RhoA is required for cortical rigidity
during mitosis is also consistent with the finding that epithe-
lial cells injected with C3 in prophase of mitosis appear to in-
crease greatly in area as, presumably, they are stretched by
neighboring cells (O’Connell et al., 1999).
 
The mechanism of RhoA activation in mitosis
 
We found that RhoA activity is elevated in preanaphase mi-
totic cells. Our results differ from those of Kimura et al.
(2000), who reported that the activity of RhoA was the same
in nocodazole-arrested mitotic cells as that in cells in S phase
of interphase. Currently, we cannot explain the apparent
discrepancy. However, the results of this previous study are
surprising because they did not observe the increase in RhoA
activity induced by microtubule depolymerization as de-
scribed by us in this work and by other studies (Enomoto,
1996; Zhang et al., 1997; Liu et al., 1998; Ren et al., 1999;
Krendel et al., 2002). The difference may be due to Kimura
et al. (2000) using the active RhoA-binding domain of
mDia, rather than Rhotekin, as was used here. We found
that p190RhoGAP activity is lower in mitosis than in inter-
phase, which correlates with the mitotic increase in the ac-
tivity of RhoA. Also, serine/threonine phosphorylation of
p190RhoGAP is elevated in mitosis, and this phosphoryla-
tion is required for mitotic down-regulation of p190Rho-
GAP. Tyrosine phosphorylation of p190RhoGAP is reduced
in mitosis. Src, which stimulates p190RhoGAP activity by
phosphorylation on tyrosines (Fincham et al., 1999), has
been shown to be highly active in mitosis (Chackalaparampil
and Shalloway, 1988). It is possible that mitotic serine/thre-
onine phosphorylation of p190RhoGAP, or elevated protein
tyrosine phosphatase activity in mitosis, blocks stimulatory
phosphorylation on tyrosine residues.
The results presented in Fig. 5 suggested that this regula-
tion of p190RhoGAP plays a role in RhoA-dependent
mitotic cell rounding. However, transient expression of
p190RhoGAP did not block rounding (Fig. 6). Importantly,
the mitotic cells that were measured likely expressed only
low levels of p190RhoGAP and consequently may still have
had adequate levels of active RhoA. Cells expressing high lev-
els of GFP–p190RhoGAP were highly retracted in inter-
phase or were apoptotic, and it is doubtful that many of
these cells entered mitosis. Also, it is possible that the exoge-
nous p190RhoGAP was properly down-regulated, and that
RhoA was activated sufficiently to elicit mitotic round-
ing.  Therefore, this approach cannot conclusively address
whether p190RhoGAP down-regulation in mitosis is re-
quired for mitotic cell rounding. We also found that mitotic
cell rounding was not blocked in Rat1 cells stably overex-
pressing p190RhoGAP at three to five times the endogenous
levels (unpublished data). However, treatment with C3 re-
vealed that mitotic cell rounding is RhoA independent in
these cells. This indicates that, at least in Rat1 cells, there is
an additional Rho-independent mechanism for this process.
Interestingly, both the elevation of p190RhoGAP and C3
treatment increased blebbing in mitotic Rat1 cells, consistent
with a role for RhoA in regulating cortical rigidity during
mitosis in these cells. Therefore, we conclude that mitotic ac-
tivation of RhoA may be due in part to p190RhoGAP
down-regulation, but that a Rho GEF likely contributes to
mitotic RhoA activation and cell rounding (Fig. 7).
 
How does RhoA activation promote 
mitotic cell rounding?
 
Studies demonstrating mitotic cortical rigidity (Mitchison
and Swann, 1955; Yoneda and Dan, 1972; Matzke et al.,
2001) have not addressed its cause. Among the factors that
could affect this physical characteristic are cytoskeletal con-
tractility under the cortex, actin filament cross-linking, and
the degree of coupling between the cortical cytoskeleton and
the membrane. RhoA, a major regulator of the actin cyto-
skeleton, can affect all three of these characteristics. We pro-
pose that RhoA and Rho-kinase promote mitotic cortical
retraction and rigidity through regulation of the actin cyto-
skeleton (Fig. 7). RhoA regulates the actin cytoskeleton in
many ways. Most attention has been directed toward the
RhoA-dependent Rho-kinase stimulation of phosphoryla-
tion of MLC and the consequent stimulation of myosin
contractility (Amano et al., 1996; Kimura et al., 1996). It
was recently shown that the rounded shape of FAK
 
 
 
/
 
 
 
 cells
is alleviated by inhibition of Rho-kinase by Y-27632, an-
other example where a rounded morphology is dependent
on RhoA and Rho-kinase activity (Chen et al., 2002). Yama-
kita et al. (1994) showed that in preanaphase mitotic cells,
the majority of MLC is phosphorylated (possibly by Cdc2
[Satterwhite et al., 1992] or a conventional PKC [Varla-
mova et al., 2001]) on residues that confer inhibition. Inhib-
itory phosphorylation of MLC blocks phosphorylation on
stimulatory residues (Nishikawa et al., 1984). Therefore,
even in the presence of high RhoA activity in mitosis, inhib-
itory phosphorylation would block stimulatory phosphory-
lation by Rho-kinase. Interestingly, Yamakita et al. (1994)
report that although 31% of MLC is phosphorylated early
in mitosis, only 15% of MLC is phosphorylated on inhibi-
tory residues at this time. This would seem to allow for the
possibility that some MLC in mitosis bears stimulatory
phosphorylation and is actively contractile. In addition,
Shuster and Burgess (1999) showed that at no time does
cortical MLC bear inhibitory phosphorylation, and that in
metaphase of mitosis, some cortical MLC bears stimulatory
phosphorylation. Further evidence for the presence of myo-
sin contractility in preanaphase mitosis comes from Sanger
et al. (1989), who performed time-lapse microscopy of mi-
tosis in cells that had been microinjected with fluorescently
labeled MLC. The labeled myosin incorporated into and lo-T
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calized to puncta along stress fibers. As cells entered mitosis
and underwent mitotic cell rounding, stress fibers shortened
and individual myosin-containing puncta along stress fibers
became closer together. Microinjected fluorescent 
 
 
 
-actinin
had a similar behavior (Sanger et al., 1987). This observa-
tion of actomyosin contractility at this stage of the cell cycle
demonstrates that myosin contractility could contribute to
the state of the cortical actin cytoskeleton at this time.
Several other Rho-kinase substrates also regulate the actin
cytoskeleton. Adducin, which links F-actin to the plasma
membrane through spectrin, is stimulated by phosphoryla-
tion by Rho-kinase (Kimura et al., 1998; Fukata et al.,
1999). The resulting enhancement of coupling between the
actin cytoskeleton and the spectrin-based membrane cyto-
skeleton could promote mitotic cortical rigidity and round-
ing. Cofilin, an actin-severing protein that promotes depoly-
merization of F-actin, is down-regulated by RhoA signaling
through Rho-kinase and inhibitory phosphorylation by
LIMK (Maekawa et al., 1999). It has recently been shown
that cofilin activity in mitosis is lower than in interphase,
but then decreases further before increasing to interphase
levels as cells undergo cytokinesis (Amano et al., 2002). Part
of this multiphasic regulation has been shown to be inde-
pendent of Rho-kinase and LIMK (Amano et al., 2002).
However, the possibility exists that elevated RhoA activity
contributes to the down-regulation of cofilin in mitosis.
This would lead to a stabilization of the actin cytoskeleton
and rigidity in rounded mitotic cells.
The formation and maintenance of stress fibers and focal
adhesions are stimulated by and require RhoA activity
(Chardin et al., 1989; Ridley and Hall, 1992). However, in
mitosis, stress fibers and the associated focal adhesions disas-
semble in the presence of high RhoA activity. Therefore,
the disassembly of these structures must be driven by a mi-
totic pathway independent of RhoA activity. One candi-
date mechanism is down-regulation of myosin contractility,
which promotes these structures. However, as discussed
above, the state of myosin activity during mitotic cell round-
ing has not been clearly defined. Another possibility is that
an actin-binding protein disrupts the interaction of actin
with myosin. Perhaps mitotic regulation of caldesmon
causes stress fiber disassembly in the presence of high RhoA
activity (Yamashiro et al., 1991). Because actomyosin con-
tractility is required to maintain focal adhesions, stress fiber
disassembly alone may be sufficient for focal adhesion disas-
sembly in mitosis. However, mitotic phosphorylation of the
cytoplasmic focal adhesion proteins FAK, p130cas, and pax-
illin could contribute to focal adhesion disassembly (Yama-
guchi et al., 1997; Yamakita et al., 1999). Alternatively, it is
possible that there are spatially distinct pools of RhoA activ-
ity in the cell during mitotic cell rounding. We are currently
investigating the mechanism for the mitotic disassembly of
stress fibers and focal adhesions in the presence of high over-
all RhoA activity.
It has long been known that most animal cells round up
during mitosis. Why is mitotic cell rounding such a univer-
sal phenomenon? Although there is no evidence for a “cell
rounding checkpoint,” Rieder et al. (1994) observed that the
height of PtK1 epithelial cells (i.e., their degree of rounding)
correlated inversely with the time taken to progress from nu-
clear envelope breakdown to anaphase onset. This suggests
that cell rounding facilitates the assembly and function of
the mitotic spindle. Mitotic cell rounding might prevent
aneuploidy and delays in mitosis by helping to center the
spindle, bringing the spindle poles together, and preventing
chromosome mono-orientation. We propose that in mitosis,
RhoA, via Rho-kinase, causes the cortex to become rigid and
spherical in shape, and thereby promotes the fidelity and
speed of chromosome alignment and segregation.
 
Materials and methods
 
Cell culture and synchronization
 
HeLa cells were maintained in DME with 10% fetal bovine serum, sup-
plemented with 10 U/ml penicillin, 10 
 
 
 
g/ml streptomycin, 0.25 
 
 
 
g/ml
amphotericin B as fungizone. Nocodazole and taxol (Paclitaxel) (Sigma-
Aldrich) were diluted in growth medium to 1 
 
 
 
M and 10 nM, respec-
tively. For G1, cells were incubated in 5 mM thymidine for 15 h, allowed
to recover in fresh growth medium for 7 h, and incubated with 1 
 
 
 
M no-
codazole for 3 h. Rounded mitotic cells were then harvested by mechan-
ical detachment or knock-off and washed out of nocodazole and allowed
to proceed through mitosis and into G1. Adherent cells were harvested
by scraping into lysis buffer. For the S phase block, cells were incubated
in 5 mM thymidine for 15 h, fresh growth medium for 9 h, and fresh thy-
midine for an additional 15 h. For the G2 block, an S phase block was
performed, and after the second thymidine treatment, fresh medium was
added for 5 h. Mitotic cells for Fig. 4 D were prepared by treating cells
with 5 mM thymidine for 15 h, allowing cells to recover for 8 h, and then
treating cells with 10 nM taxol for 3 h. Rounded mitotic cells were har-
vested by mechanical detachment.
For C3 treatment, 0.28 
 
 
 
g GST–C3 (prepared as in Worthylake et al.,
2001) per 24-well plate well was incubated in serum-free medium and 1.7
 
 
 
l LipofectAmine (Invitrogen) and then added to cells in serum-free me-
dium. Cells were incubated with GST–C3 or GST alone for 90 min, fixed,
and processed for microscopy. For Y-27632 treatment, cells were treated
with 10 
 
 
 
M Y-27632 (Welfide Corp.) for 1 h (2 h for rigidity experiments)
in growth medium.
 
Determination of relative cell rigidity
 
HeLa cells were treated with GST or GST–C3 as for Fig. 1, or with Y-27632
as above. Cells in metaphase of mitosis were identified by phase contrast
microscopy (Nikon or Carl Zeiss MicroImaging, Inc.) as having a
metaphase plate of condensed chromatin. A glass microneedle was
brought laterally to the surface of the cell. Using the micromanipulator
(Narishige or Eppendorf) manual control dials, the microneedle shaft was
moved laterally to standardized distances (0, 25, 50, 75, 100, and 125
 
 
 
m), and images of the cell and the needle tip were captured for each dis-
tance of shaft movement, which corresponds to the amount of pressure ap-
plied. The location of the microneedle tip against the cell was plotted.
Stiffness, or rigidity, is defined as force/change in length. Cell rigidity is
plotted as the distance of deformation per amount of force, or pressure, ap-
plied. The same needle was used for control and untreated cell measure-
ments within each experiment.
 
Immunofluorescence and immunoblotting
 
To visualize actin and DNA, cells plated on glass coverslips were fixed for
10 min in 3.7% formaldehyde in PBS, permeabilized for 5 min in 0.5%
Triton X-100 in TBS (150 mM NaCl, 50 mM Tris-Cl, pH 7.6), and washed
in TBS containing 0.1% azide. Coverslips were washed in TBS 
 
 
 
 azide.
Cells were labeled with Alexa
 
®
 
594 phalloidin (Molecular Probes), Hoechst
33342 (Molecular Probes), or a monoclonal anti-paxillin antibody (BD
Biosciences) and an AlexaFluor
 
®
 
488 secondary anti–mouse antibody (Mo-
lecular Probes). Images were collected using a Carl Zeiss MicroImaging,
Inc. Axiophot with a Micromax cooled CCD camera (Princeton Instru-
ments) driven by Metamorph software (Universal Imaging Corp.). We used
primary antibodies to RhoA, p190RhoGAP, p120RasGAP, and HRP-conju-
gated anti-phosphotyrosine (mouse monoclonals; BD Biosciences) and an
HRP-conjugated anti–mouse secondary antibody (Jackson ImmunoRe-
search Laboratories).
 
RhoA activity assay
 
The RhoA activity pulldown assay was performed as published (Arthur and
Burridge, 2001).T
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Immunoprecipitations
HeLa cells were treated overnight with 10 nM taxol, and rounded mitotic
cells were collected by knock-off (mechanical disruption). The remaining
adherent cells comprised the interphase sample. For immunoblotting,
coimmunoprecipitation with p120RasGAP, and PP1 treatment, cells were
lysed in a modified RIPA buffer (150 mM NaCl, 6 mM Na2HPO4, 4 mM
NaH2PO4, 1% deoxycholic acid, 1% NP-40, 0.1% SDS, 2 mM EDTA, 10
 g/ml leupeptin, 10  g/ml aprotinin, 1 mM orthovanadate, 1 mM PMSF, 50
nM calyculin A) and precleared with anti–mouse-conjugated beads (Sigma-
Aldrich). Lysates were clarified by centrifugation, protein concentrations
were determined and adjusted to equal levels, and lysates were incubated
with anti-p190RhoGAP (3  l/500  g total protein; BD Biosciences) at 4 C
for 1.5 h. Anti–mouse IgG beads were added and incubated for an addi-
tional 30 min. Beads were washed three times in lysis buffer and prepared
for SDS-PAGE by boiling in sample buffer. For GAP assays, immunoprecip-
itations were performed as published (Fincham et al., 1999).
PP1 treatment
Sedimented p190RhoGAP on beads from immunoprecipitations, as de-
scribed above, was washed two times into reaction buffer (50 mM imida-
zole, pH 7.0, 0.25 mM MnCl2, 5 mM DTT, 100 mM KCl, 2 mM MgCl2, 0.2
mg/ml BSA) and divided equally for the following treatments. One sample
was left untreated, one sample received PP1 (Calbiochem) alone (1 U),
one sample received okadaic acid (final concentration 4  M) before addi-
tion of PP1, and the fourth sample received vanadate (final concentration 2
mM) before PP1. Reactions were incubated at 30 C for 30 min and
stopped by the addition of sample buffer and boiling.
GAP activity assay
GAP assays were performed as published (Fincham et al., 1999).
Transfections
Transient transfections were performed with LipofectAmine Plus (GIBCO
BRL) according to the manufacturer’s instructions.
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